Americans paid more for prescription drugs each year that Barack Obama was president.
The government just released new numbers that every network is scrambling to explain away.
What those numbers show about prescription drug prices is something Washington, DC promised you could never happen.
The Numbers Washington Didn't Want You to See
Prescription drug prices fell 0.8 percent in July alone.
That was no accident.
Prices have now fallen in five of the last seven months in 2026 and have not risen once.
Compared to one year ago, Americans are paying 3.1 percent less for their prescriptions – the steepest annual decline since March 1963.
https://twitter.com/EricLDaugh/status/2087969784025493894?s=20
Renaissance Macro crunched the annualized rate over the last six months and came up with a number that stopped Wall Street cold: 6.6 percent.
That is the sharpest six-month drop on record.
Not the sharpest in a decade.
Not the sharpest since the pandemic.
The sharpest ever.
What Trump Actually Did While Democrats Said It Was Impossible
The Left spent years telling you drug companies were untouchable.
They were wrong.
In May 2025, Trump signed an Executive Order demanding Most-Favored-Nation pricing – meaning Americans would pay no more for a pill than the lowest price any developed nation pays for that identical drug.
Democrats called it a fantasy.
Trump called it a promise.
Then he started collecting signatures.
Pfizer signed in September 2025.
AstraZeneca signed in October.
Eli Lilly and Novo Nordisk – the two companies that control the most expensive drugs in America – signed in November, slashing Ozempic from $1,000 a month to $350 and Wegovy from $1,350 a month to $350.
https://twitter.com/WhiteHouse/status/2087958817967403083?s=20
By February 2026, TrumpRx.gov was live – a direct platform letting Americans buy medicines at MFN prices without fighting their insurance company.
The catalog now covers more than 800 medications.
Non-prescription drug prices joined the slide too, falling 0.3 percent in July and down 1.7 percent over the past year.
How One Executive Order Ended 40 Years of Pharmaceutical Freeloading
Americans make up a small fraction of the world's population but have been bankrolling the majority of global pharmaceutical profits for decades.
The arrangement worked like a cartel: drug companies deeply discounted their products in European and Asian markets to gain access, then made up the difference by charging Americans three, four, sometimes five times more for the same medication.
That gap was not a market outcome – it was a system, built deal by deal, regulation by regulation, over decades of politicians who took pharmaceutical money and looked the other way.
Trump did not take the money.
He took the fight.
The December 2025 UK trade agreement is part of the same strategy – pushing other developed nations to pay their fair share instead of passing the cost to American patients.
When every country pays closer to the same price, the system that justified charging Americans more collapses.
The media will insist this was already happening, that Biden's drug negotiations deserve the credit, that Trump just showed up for the ribbon cutting.
https://twitter.com/RapidResponse47/status/2087949207285981226?s=20
That is a lie worth knowing.
Biden's IRA negotiations covered a handful of Medicare drugs and moved slowly through a bureaucratic process.
Trump's MFN executive order went directly at the pharmaceutical companies themselves and forced public commitments within months.
Your grandfather paid less for his heart medication last month than he did last year.
That is a real thing that happened because one president decided American patients deserved the same deal every other country already had.
Sources:
- John Carney, "Trump Effect: Prescription Drug Prices Fall At Record-Breaking Pace," Breitbart, August 12, 2026.
- "Consumer Price Index Summary – 2026 M07 Results," Bureau of Labor Statistics, August 12, 2026.
- "Fact Sheet: President Donald J. Trump Announces Major Developments in Bringing Most-Favored-Nation Pricing to American Patients," The White House, November 6, 2025.
- "Fact Sheet: President Donald J. Trump Announces Second Deal to Bring Most-Favored-Nation Pricing to American Patients," The White House, October 10, 2025.
- "HHS, CMS Set Most-Favored-Nation Pricing Targets to End Global Freeloading on American Patients," U.S. Department of Health and Human Services, May 20, 2025.
